News Summary: New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect sample analytes. Gives more scientists greater access to MS data to improve quality, reduce costs, and ultimately help get medicines to patients faster. MILFORD, Mass. — Waters Corporation (NYSE:WAT) today introduced […]
Under the agreement, Evotec will utilize Biognosys’ proprietary proteomics data analysis platform to accelerate and de-risk drug development September 14th, 2021 – SCHLIEREN (Zurich, Switzerland) – Biognosys, an innovator and leader in next-generation proteomics technology and solutions for life sciences research, announced today that they have entered a collaboration with Evotec, a life science company […]
Framingham, MA — SCIEX, a global leader in life science analytical technologies and Danaher operating company, launches Biologics Explorer software, enabling customers to acquire insights from their high-resolution protein characterization data, and reach decisions quickly and confidently on the most important critical quality attributes for biopharmaceuticals. Biologics Explorer signifies the next step in innovation, building upon the […]
The two companies will work with the Environmental Molecular Science Laboratory, a U.S. Department of Energy user facility located at PNNL, and will leverage Cellenion’s flagship platform for single cell isolation and nanoliter dispensing Today, SCIENION and Cellenion, drivers of BICO, a leading bio convergence company, announced that they have exclusively licensed a PNNL invention and have also […]
CUPERTINO, Calif. — Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software, announced today the addition of Steve Cypes, Vice President of Global Sales and Services, to their leadership team. Prior to joining Protein Metrics, Steve served as the Vice President of Workflow Sales at Unchained Labs for five years. There he had worldwide responsibility […]
A UK-based consortium consisting of BiologIC Technologies, Biopharm Services, CPI, Pall Corporation, and SCIEX has announced the launch of a project that aims to develop automated manufacturing controls for use in the manufacture of biologics. The project, worth a total of £3.1million, including equipment contributions, has received support from Innovate UK, to platform this advanced technology. While the accelerated development and […]
The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process Basel, Switzerland and Framingham, MA, USA—July 29, 2021—Genedata, leading provider of biopharma enterprise software solutions, and SCIEX, a global leader in life science analytical technologies, have entered into a strategic partnership to develop new […]
Capital Partners to Expand Commercial Activities and Accelerate Product Development CHADDS FORD, Pa. — MOBILion Systems Inc., a pioneer in fast, efficient, highresolution instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, today announced the close of a $60 million Series C financing round. The round was led by D1 Capital Partners with the remaining funds contributed by existing investors […]
Center will develop new technologies and reproducible analytical techniques to support rapid, cost-effective clinical research into applications for metabolomics in precision medicine SAN JOSE, Calif. and DAVIS, Calif. — Thermo Fisher Scientific, (NYSE: TMO) the world leader in serving science, and the University of California, Davis (UC Davis) West Coast Metabolomics Center today announced The […]
LCMS-8060NX Triple Quadrupole Liquid Chromatograph Mass Spectrometer Shimadzu has released the LC/MS/MS Method Package for Modified Nucleosides.*1 Using this method package, biomarker candidates (two kinds of modified nucleosides) that show a correlation to increase severity of COVID-19 symptoms can be measured in six minutes*2. This method package is used in conjunction with a modified nucleoside analysis […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
